FOLLOW US :
  • |
  • |

Equity

Daily Market Tracker
Market Analysis
Other Markets
Corporate Actions
News
Corporate Information

Prev Quarter Comp Home > Equity > Corporate Information > Prev Quarter Comp

Balaxi Pharmaceuticals LtdIndustry : Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code:532597 NSE Symbol: BALAXI P/E (TTM) :75.49
ISIN Demat:INE618N01022 Div & Yield %:0 EPS (TTM) :0.65
Book Value (RS) :23.1583571 Market Cap (Rs Cr.):270.9 Face Value (RS) :2
    Change Company 
Particulars Quarter Ended
(Mar 2025)		 Quarter Ended
(Mar 2024)		 Quarter Ended
(% Var)
Sales 9.65 15.90 -39.31
Other Income 0.32 0.16 100.00
PBIDT -0.33 0.36 -191.67
Interest 0.69 0.51 35.29
PBDT -1.03 -0.15 0.00
Depreciation 0.11 0.12 -8.33
PBT -1.14 -0.27 0.00
Tax 0.08 0.38 -78.95
Deferred Tax -0.04 -0.07 0.00
PAT -1.18 -0.58 0.00

IMPORTANT LINKS

QUICK LINKS

FOR GRIEVANCE MAIL TO invgrieviss@iseindia.com

BSE EQUITIES : INB011077733 | NSE F&O EQUITIES : INF231077737 | NSE CASH MARKET : INB231077737 | NSE CURRENCY DERIVATIVES : INE231077737 | MCX-SX : INE261077737

ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited], a wholly owned subsidiary of Inter-connected Stock Exchange of India Ltd. (ISE)

© 2013 ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited]. All rights reserved.

Designed, developed & powered by C-MOTS Infotech (ISO 9001:2008 certified)